nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.101	0.165	CbGbCtD
Fenofibrate—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0928	0.152	CbGbCtD
Fenofibrate—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0928	0.152	CbGbCtD
Fenofibrate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0712	0.117	CbGbCtD
Fenofibrate—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0703	0.115	CbGbCtD
Fenofibrate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0481	0.0789	CbGbCtD
Fenofibrate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0459	0.0753	CbGbCtD
Fenofibrate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0409	0.0671	CbGbCtD
Fenofibrate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.024	0.0394	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0227	0.0372	CbGbCtD
Fenofibrate—PPARA—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00407	0.0509	CbGpPWpGaD
Fenofibrate—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00317	0.0396	CbGpPWpGaD
Fenofibrate—PPARA—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00296	0.037	CbGpPWpGaD
Fenofibrate—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.0028	0.035	CbGpPWpGaD
Fenofibrate—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—chronic obstructive pulmonary disease	0.00233	0.0291	CbGpPWpGaD
Fenofibrate—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00229	0.0287	CbGpPWpGaD
Fenofibrate—Indomethacin—CXCL8—chronic obstructive pulmonary disease	0.00212	0.363	CrCbGaD
Fenofibrate—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00195	0.0244	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00189	0.0236	CbGpPWpGaD
Fenofibrate—Clofibrate—CYP1A1—chronic obstructive pulmonary disease	0.00183	0.314	CrCbGaD
Fenofibrate—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00181	0.0226	CbGpPWpGaD
Fenofibrate—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00177	0.0222	CbGpPWpGaD
Fenofibrate—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00159	0.0198	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00147	0.0184	CbGpPWpGaD
Fenofibrate—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00144	0.018	CbGpPWpGaD
Fenofibrate—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00142	0.0177	CbGpPWpGaD
Fenofibrate—Bezafibrate—CYP1A1—chronic obstructive pulmonary disease	0.00133	0.229	CrCbGaD
Fenofibrate—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00129	0.0161	CbGpPWpGaD
Fenofibrate—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.0145	CbGpPWpGaD
Fenofibrate—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00115	0.0144	CbGpPWpGaD
Fenofibrate—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00105	0.0131	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—chronic obstructive pulmonary disease	0.000997	0.0125	CbGpPWpGaD
Fenofibrate—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000936	0.0117	CbGpPWpGaD
Fenofibrate—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0009	0.0113	CbGpPWpGaD
Fenofibrate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000892	0.0112	CbGpPWpGaD
Fenofibrate—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.000873	0.0109	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000801	0.01	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00079	0.00988	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000784	0.0098	CbGpPWpGaD
Fenofibrate—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000762	0.00953	CbGpPWpGaD
Fenofibrate—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000733	0.00916	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.000731	0.00914	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000704	0.00881	CbGpPWpGaD
Fenofibrate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000692	0.00865	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.000683	0.00853	CbGpPWpGaD
Fenofibrate—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00068	0.0085	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000656	0.0082	CbGpPWpGaD
Fenofibrate—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000654	0.00818	CbGpPWpGaD
Fenofibrate—PPARA—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.000636	0.00795	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.000619	0.00774	CbGpPWpGaD
Fenofibrate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000601	0.00751	CbGpPWpGaD
Fenofibrate—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000554	0.00692	CbGpPWpGaD
Fenofibrate—Indomethacin—ALB—chronic obstructive pulmonary disease	0.00055	0.0944	CrCbGaD
Fenofibrate—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000547	0.00683	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00054	0.00675	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000536	0.0067	CbGpPWpGaD
Fenofibrate—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000532	0.00666	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000525	0.00656	CbGpPWpGaD
Fenofibrate—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000524	0.00654	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000504	0.0063	CbGpPWpGaD
Fenofibrate—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000503	0.00628	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000498	0.00623	CbGpPWpGaD
Fenofibrate—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000483	0.00604	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000463	0.00578	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000461	0.00576	CbGpPWpGaD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00045	0.00562	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000437	0.00546	CbGpPWpGaD
Fenofibrate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000436	0.00546	CbGpPWpGaD
Fenofibrate—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000419	0.00524	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000407	0.00509	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000398	0.00497	CbGpPWpGaD
Fenofibrate—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000397	0.00497	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.00486	CbGpPWpGaD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.0048	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.00458	CbGpPWpGaD
Fenofibrate—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000365	0.00456	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000362	0.00452	CbGpPWpGaD
Fenofibrate—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000351	0.00439	CbGpPWpGaD
Fenofibrate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00113	CcSEcCtD
Fenofibrate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00113	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00113	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00113	CcSEcCtD
Fenofibrate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00112	CcSEcCtD
Fenofibrate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00112	CcSEcCtD
Fenofibrate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Fenofibrate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Fenofibrate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Fenofibrate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Fenofibrate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00111	CcSEcCtD
Fenofibrate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00111	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00111	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000336	0.0011	CcSEcCtD
Fenofibrate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.0011	CcSEcCtD
Fenofibrate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000335	0.0011	CcSEcCtD
Fenofibrate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00109	CcSEcCtD
Fenofibrate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00109	CcSEcCtD
Fenofibrate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00109	CcSEcCtD
Fenofibrate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000331	0.00109	CcSEcCtD
Fenofibrate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00108	CcSEcCtD
Fenofibrate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00108	CcSEcCtD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000329	0.00411	CbGpPWpGaD
Fenofibrate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00107	CcSEcCtD
Fenofibrate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00107	CcSEcCtD
Fenofibrate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00107	CcSEcCtD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.00409	CbGpPWpGaD
Fenofibrate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000327	0.00107	CcSEcCtD
Fenofibrate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00107	CcSEcCtD
Fenofibrate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00107	CcSEcCtD
Fenofibrate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00107	CcSEcCtD
Fenofibrate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000325	0.00107	CcSEcCtD
Fenofibrate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00107	CcSEcCtD
Fenofibrate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00106	CcSEcCtD
Fenofibrate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00106	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000324	0.00405	CbGpPWpGaD
Fenofibrate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00106	CcSEcCtD
Fenofibrate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00106	CcSEcCtD
Fenofibrate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.00106	CcSEcCtD
Fenofibrate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00106	CcSEcCtD
Fenofibrate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00106	CcSEcCtD
Fenofibrate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000321	0.00105	CcSEcCtD
Fenofibrate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00105	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.00032	0.004	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00105	CcSEcCtD
Fenofibrate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00104	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000316	0.00396	CbGpPWpGaD
Fenofibrate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00104	CcSEcCtD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00394	CbGpPWpGaD
Fenofibrate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00103	CcSEcCtD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000312	0.0039	CbGpPWpGaD
Fenofibrate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00102	CcSEcCtD
Fenofibrate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00102	CcSEcCtD
Fenofibrate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00102	CcSEcCtD
Fenofibrate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.00102	CcSEcCtD
Fenofibrate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00101	CcSEcCtD
Fenofibrate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00101	CcSEcCtD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000307	0.00383	CbGpPWpGaD
Fenofibrate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.001	CcSEcCtD
Fenofibrate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.000999	CcSEcCtD
Fenofibrate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000303	0.000994	CcSEcCtD
Fenofibrate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000994	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000302	0.000992	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.000992	CcSEcCtD
Fenofibrate—PPARA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000302	0.00377	CbGpPWpGaD
Fenofibrate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0003	0.000985	CcSEcCtD
Fenofibrate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.000985	CcSEcCtD
Fenofibrate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00098	CcSEcCtD
Fenofibrate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.000979	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000296	0.000972	CcSEcCtD
Fenofibrate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000296	0.000971	CcSEcCtD
Fenofibrate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.000971	CcSEcCtD
Fenofibrate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.000968	CcSEcCtD
Fenofibrate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000295	0.000968	CcSEcCtD
Fenofibrate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000294	0.000965	CcSEcCtD
Fenofibrate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.000961	CcSEcCtD
Fenofibrate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000292	0.000959	CcSEcCtD
Fenofibrate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.000959	CcSEcCtD
Fenofibrate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.000958	CcSEcCtD
Fenofibrate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.000955	CcSEcCtD
Fenofibrate—Injury—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000949	CcSEcCtD
Fenofibrate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000289	0.000948	CcSEcCtD
Fenofibrate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.000946	CcSEcCtD
Fenofibrate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.000944	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000287	0.00359	CbGpPWpGaD
Fenofibrate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00094	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00094	CcSEcCtD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000286	0.00358	CbGpPWpGaD
Fenofibrate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000286	0.000939	CcSEcCtD
Fenofibrate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000939	CcSEcCtD
Fenofibrate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000939	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.000937	CcSEcCtD
Fenofibrate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.000931	CcSEcCtD
Fenofibrate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.000931	CcSEcCtD
Fenofibrate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000284	0.000931	CcSEcCtD
Fenofibrate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000284	0.000931	CcSEcCtD
Fenofibrate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00093	CcSEcCtD
Fenofibrate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000928	CcSEcCtD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000282	0.00353	CbGpPWpGaD
Fenofibrate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000923	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000921	CcSEcCtD
Fenofibrate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00092	CcSEcCtD
Fenofibrate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000917	CcSEcCtD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00348	CbGpPWpGaD
Fenofibrate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.000914	CcSEcCtD
Fenofibrate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000278	0.000912	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000912	CcSEcCtD
Fenofibrate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00091	CcSEcCtD
Fenofibrate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.000907	CcSEcCtD
Fenofibrate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.000905	CcSEcCtD
Fenofibrate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.000902	CcSEcCtD
Fenofibrate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.000902	CcSEcCtD
Fenofibrate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.000899	CcSEcCtD
Fenofibrate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000898	CcSEcCtD
Fenofibrate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000898	CcSEcCtD
Fenofibrate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.000897	CcSEcCtD
Fenofibrate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.000894	CcSEcCtD
Fenofibrate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.000892	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.000891	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000271	0.000891	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.000888	CcSEcCtD
Fenofibrate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000887	CcSEcCtD
Fenofibrate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.000879	CcSEcCtD
Fenofibrate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.000879	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000268	0.00335	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.00333	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000266	0.000872	CcSEcCtD
Fenofibrate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000872	CcSEcCtD
Fenofibrate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.000865	CcSEcCtD
Fenofibrate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000264	0.000865	CcSEcCtD
Fenofibrate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000262	0.000861	CcSEcCtD
Fenofibrate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000262	0.000861	CcSEcCtD
Fenofibrate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.000861	CcSEcCtD
Fenofibrate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.000861	CcSEcCtD
Fenofibrate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.000858	CcSEcCtD
Fenofibrate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.000851	CcSEcCtD
Fenofibrate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00085	CcSEcCtD
Fenofibrate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00085	CcSEcCtD
Fenofibrate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000258	0.000848	CcSEcCtD
Fenofibrate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000848	CcSEcCtD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00323	CbGpPWpGaD
Fenofibrate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.000845	CcSEcCtD
Fenofibrate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000257	0.000843	CcSEcCtD
Fenofibrate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000257	0.000843	CcSEcCtD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00321	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.000841	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000256	0.0032	CbGpPWpGaD
Fenofibrate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.000817	CcSEcCtD
Fenofibrate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.000813	CcSEcCtD
Fenofibrate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.000813	CcSEcCtD
Fenofibrate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000245	0.000802	CcSEcCtD
Fenofibrate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.000802	CcSEcCtD
Fenofibrate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.000802	CcSEcCtD
Fenofibrate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.0008	CcSEcCtD
Fenofibrate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00024	0.000786	CcSEcCtD
Fenofibrate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000238	0.000781	CcSEcCtD
Fenofibrate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.000781	CcSEcCtD
Fenofibrate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000771	CcSEcCtD
Fenofibrate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000771	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000769	CcSEcCtD
Fenofibrate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000769	CcSEcCtD
Fenofibrate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000233	0.000765	CcSEcCtD
Fenofibrate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.000758	CcSEcCtD
Fenofibrate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00023	0.000755	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00023	0.00287	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00286	CbGpPWpGaD
Fenofibrate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.000745	CcSEcCtD
Fenofibrate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000227	0.000745	CcSEcCtD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.00284	CbGpPWpGaD
Fenofibrate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.000742	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000226	0.00282	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000225	0.00282	CbGpPWpGaD
Fenofibrate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000739	CcSEcCtD
Fenofibrate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.000738	CcSEcCtD
Fenofibrate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00073	CcSEcCtD
Fenofibrate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000728	CcSEcCtD
Fenofibrate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.000723	CcSEcCtD
Fenofibrate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00072	CcSEcCtD
Fenofibrate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00072	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000215	0.00269	CbGpPWpGaD
Fenofibrate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000215	0.000705	CcSEcCtD
Fenofibrate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000704	CcSEcCtD
Fenofibrate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000213	0.00267	CbGpPWpGaD
Fenofibrate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000694	CcSEcCtD
Fenofibrate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000211	0.000693	CcSEcCtD
Fenofibrate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.000693	CcSEcCtD
Fenofibrate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.000687	CcSEcCtD
Fenofibrate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000209	0.000687	CcSEcCtD
Fenofibrate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.000686	CcSEcCtD
Fenofibrate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000209	0.000686	CcSEcCtD
Fenofibrate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000686	CcSEcCtD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00261	CbGpPWpGaD
Fenofibrate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.000682	CcSEcCtD
Fenofibrate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000208	0.000682	CcSEcCtD
Fenofibrate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000682	CcSEcCtD
Fenofibrate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00068	CcSEcCtD
Fenofibrate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000207	0.000678	CcSEcCtD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000206	0.00257	CbGpPWpGaD
Fenofibrate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000205	0.000673	CcSEcCtD
Fenofibrate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000205	0.000672	CcSEcCtD
Fenofibrate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000671	CcSEcCtD
Fenofibrate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000204	0.000668	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000663	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000202	0.00252	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000201	0.00252	CbGpPWpGaD
Fenofibrate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000659	CcSEcCtD
Fenofibrate—PPARA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0002	0.0025	CbGpPWpGaD
Fenofibrate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.000654	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000199	0.00249	CbGpPWpGaD
Fenofibrate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.000652	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.00248	CbGpPWpGaD
Fenofibrate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000649	CcSEcCtD
Fenofibrate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.000648	CcSEcCtD
Fenofibrate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000648	CcSEcCtD
Fenofibrate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000197	0.000647	CcSEcCtD
Fenofibrate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.000647	CcSEcCtD
Fenofibrate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000644	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GC—chronic obstructive pulmonary disease	0.000194	0.00243	CbGpPWpGaD
Fenofibrate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000193	0.000634	CcSEcCtD
Fenofibrate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000624	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000188	0.00236	CbGpPWpGaD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00234	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00233	CbGpPWpGaD
Fenofibrate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000611	CcSEcCtD
Fenofibrate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.000608	CcSEcCtD
Fenofibrate—PPARA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000181	0.00226	CbGpPWpGaD
Fenofibrate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000593	CcSEcCtD
Fenofibrate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00059	CcSEcCtD
Fenofibrate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000576	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00057	CcSEcCtD
Fenofibrate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000564	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000169	0.00211	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00209	CbGpPWpGaD
Fenofibrate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000547	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00206	CbGpPWpGaD
Fenofibrate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000539	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000164	0.00205	CbGpPWpGaD
Fenofibrate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000534	CcSEcCtD
Fenofibrate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000533	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000162	0.00203	CbGpPWpGaD
Fenofibrate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00053	CcSEcCtD
Fenofibrate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000529	CcSEcCtD
Fenofibrate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000525	CcSEcCtD
Fenofibrate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000525	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000155	0.00194	CbGpPWpGaD
Fenofibrate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000504	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000152	0.0019	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.0019	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00187	CbGpPWpGaD
Fenofibrate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000487	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000486	CcSEcCtD
Fenofibrate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000485	CcSEcCtD
Fenofibrate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000474	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0018	CbGpPWpGaD
Fenofibrate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000472	CcSEcCtD
Fenofibrate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000469	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000142	0.00177	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.00014	0.00175	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00014	0.00175	CbGpPWpGaD
Fenofibrate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000453	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000138	0.00172	CbGpPWpGaD
Fenofibrate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000447	CcSEcCtD
Fenofibrate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000447	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.0017	CbGpPWpGaD
Fenofibrate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000446	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000444	CcSEcCtD
Fenofibrate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000442	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00168	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000435	CcSEcCtD
Fenofibrate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000429	CcSEcCtD
Fenofibrate—Infection—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000426	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000128	0.0016	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00042	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000418	CcSEcCtD
Fenofibrate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000416	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000127	0.00158	CbGpPWpGaD
Fenofibrate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000414	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000409	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000123	0.00154	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00154	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00152	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.0015	CbGpPWpGaD
Fenofibrate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000391	CcSEcCtD
Fenofibrate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00039	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000388	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000385	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000117	0.00147	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000117	0.00146	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000115	0.00144	CbGpPWpGaD
Fenofibrate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000377	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000115	0.00144	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000114	0.00142	CbGpPWpGaD
Fenofibrate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000373	CcSEcCtD
Fenofibrate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000372	CcSEcCtD
Fenofibrate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000372	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00037	CcSEcCtD
Fenofibrate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00037	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000112	0.0014	CbGpPWpGaD
Fenofibrate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000367	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000108	0.00135	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000353	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000107	0.00134	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000107	0.00134	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000351	CcSEcCtD
Fenofibrate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00035	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00133	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000105	0.00131	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00131	CbGpPWpGaD
Fenofibrate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000341	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000339	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000339	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000103	0.00129	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.9e-05	0.00124	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.79e-05	0.00122	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	9.79e-05	0.00122	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.76e-05	0.00122	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.000316	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CTGF—chronic obstructive pulmonary disease	9.58e-05	0.0012	CbGpPWpGaD
Fenofibrate—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000308	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.31e-05	0.00116	CbGpPWpGaD
Fenofibrate—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000303	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.99e-05	0.00112	CbGpPWpGaD
Fenofibrate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000293	CcSEcCtD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.86e-05	0.00111	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.83e-05	0.0011	CbGpPWpGaD
Fenofibrate—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000283	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	8.41e-05	0.00105	CbGpPWpGaD
Fenofibrate—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000273	CcSEcCtD
Fenofibrate—Rash—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.00027	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.00027	CcSEcCtD
Fenofibrate—Headache—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000269	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.96e-05	0.000996	CbGpPWpGaD
Fenofibrate—Nausea—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000255	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	7.55e-05	0.000944	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.49e-05	0.000937	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.39e-05	0.000924	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.36e-05	0.00092	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.26e-05	0.000908	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.98e-05	0.000872	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.93e-05	0.000867	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.89e-05	0.000861	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.8e-05	0.00085	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.79e-05	0.000849	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.77e-05	0.000846	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.53e-05	0.000816	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.48e-05	0.00081	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TNF—chronic obstructive pulmonary disease	6.47e-05	0.000809	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.44e-05	0.000805	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.000804	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.000802	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	6.31e-05	0.000788	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.86e-05	0.000733	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.68e-05	0.00071	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.62e-05	0.000702	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.28e-05	0.00066	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.25e-05	0.000657	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.23e-05	0.000654	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—IL6—chronic obstructive pulmonary disease	5.23e-05	0.000653	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.13e-05	0.000642	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.77e-05	0.000596	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.67e-05	0.000584	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ALB—chronic obstructive pulmonary disease	4.36e-05	0.000545	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NOS3—chronic obstructive pulmonary disease	4.17e-05	0.000521	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.8e-05	0.000475	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.48e-05	0.000435	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.44e-05	0.000431	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.41e-05	0.000426	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.38e-05	0.000423	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.17e-05	0.000397	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.15e-05	0.000393	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.11e-05	0.000388	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.86e-05	0.000358	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.8e-05	0.00035	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.77e-05	0.000346	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.58e-05	0.000323	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.53e-05	0.000316	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.39e-05	0.000298	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.35e-05	0.000294	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.33e-05	0.000291	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.19e-05	0.000274	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.08e-05	0.00026	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.94e-05	0.000243	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.92e-05	0.00024	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.85e-05	0.000231	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.83e-05	0.000228	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.79e-05	0.000223	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000212	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.67e-05	0.000208	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.000192	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.41e-05	0.000177	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000169	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.00016	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000158	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000147	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.15e-05	0.000144	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.00014	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.1e-05	0.000138	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.59e-06	9.49e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.26e-06	9.08e-05	CbGpPWpGaD
